HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,285,117 | -10.3% | 159,019 | +18.9% | 0.66% | -8.5% |
Q2 2023 | $2,546,486 | -20.1% | 133,744 | -11.2% | 0.72% | -23.2% |
Q1 2023 | $3,186,886 | +113636.1% | 150,609 | -20.7% | 0.94% | +13271.4% |
Q4 2022 | $2,802 | -99.9% | 189,839 | -4.5% | 0.01% | +16.7% |
Q3 2022 | $2,399,000 | -76.6% | 198,764 | +0.6% | 0.01% | -73.9% |
Q2 2022 | $10,269,000 | +2.3% | 197,664 | +11.3% | 0.02% | +4.5% |
Q1 2022 | $10,041,000 | -23.6% | 177,520 | +15.2% | 0.02% | -26.7% |
Q4 2021 | $13,150,000 | -0.6% | 154,080 | -0.5% | 0.03% | 0.0% |
Q3 2021 | $13,226,000 | +0.4% | 154,900 | +30.1% | 0.03% | -3.2% |
Q2 2021 | $13,170,000 | +2442.5% | 119,025 | +55.0% | 0.03% | +3000.0% |
Q1 2021 | $518,000 | +5.9% | 76,775 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $489,000 | +40.9% | 71,325 | +14.8% | 0.00% | – |
Q3 2020 | $347,000 | +7.4% | 62,150 | 0.0% | 0.00% | – |
Q2 2020 | $323,000 | +39.8% | 62,150 | +2.5% | 0.00% | – |
Q1 2020 | $231,000 | +16.1% | 60,650 | +164.3% | 0.00% | – |
Q2 2019 | $199,000 | – | 22,950 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |